KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Assets (2016 - 2025)

Teva Pharmaceutical Industries (TEVA) has disclosed Return on Assets for 9 consecutive years, with 0.04% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 9.0% year-over-year to 0.04%, compared with a TTM value of 0.04% through Dec 2025, up 9.0%, and an annual FY2025 reading of 0.04%, up 8.0% over the prior year.
  • Return on Assets was 0.04% for Q4 2025 at Teva Pharmaceutical Industries, up from 0.02% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.04% in Q4 2025 and bottomed at 0.08% in Q1 2021.
  • Average Return on Assets over 5 years is 0.03%, with a median of 0.03% recorded in 2022.
  • Peak annual rise in Return on Assets hit 10bps in 2021, while the deepest fall reached -8bps in 2021.
  • Year by year, Return on Assets stood at 0.01% in 2021, then tumbled by -709bps to 0.06% in 2022, then soared by 73bps to 0.02% in 2023, then tumbled by -217bps to 0.05% in 2024, then skyrocketed by 179bps to 0.04% in 2025.
  • Business Quant data shows Return on Assets for TEVA at 0.04% in Q4 2025, 0.02% in Q3 2025, and 0.01% in Q2 2025.